CHESTThoracic Oncology

Thoracic Oncology

In brief: what’s new and notable in thoracic oncology

Explore new and notable updates in thoracic oncology, including research into using FEV1 as a biomarker for the development of lung cancer, complications after lung cancer screening, and frailty in patients with lung cancer. Read the latest updates on thoracic oncology in the CHEST Physician® publication, access webinars on important topics in oncology, and more.

Thoracic oncology resources for patients and clinicians

Clinician education resources to explore

Lung cancer screening
WEBINAR

Lung Cancer Screening and Treatment of Early Stage

Review current guidelines in lung cancer screening and treatment—and hear personal experiences from experts in the field—in this webinar recording.

Game of Nodules
PLAYER HUB

Game of Nodules

Test your knowledge by facing multiple levels of challenging clinical questions about treating patients with lung nodules in this interactive game.

Optimal tissue acquisition
WEBINAR

Optimal Tissue Acquisition, Handling, and Processing NGS and PD-L1 Testing

Explore various strategies for improving the quantity and quality of cytology and small volume biopsy specimens, with tips from expert pathologists and a medical oncologist.


Laptop image

Patient education resources to share

A diagnosis of lung cancer can be devastating for patients. Help them better understand every aspect of the disease with this page from the CHEST Foundation. Information covers everything from symptoms to watch for, treatment options, and the unique ways women may experience lung cancer to other resources to help them cope. Patients can review the PDF patient guide for more in-depth information or access infographics on what they need to know about lung cancer and biopsies for quick-hit answers.

LEARN MORE ABOUT LUNG CANCER »

Laptop image

Thoracic oncology news and notes

Follow the latest thoracic oncology news

CHEST PHYSICIAN

Mind the gap: Improving adherence to lung cancer screening follow-up
Lung cancer screening is shown to improve outcomes, but adherence with follow-up is often poor. Review details about this gap and recommendations for improving adherence.

Role of EBUS for staging and prognostication in patients with lung cancer
Accurate staging is imperative when making treatment decisions for patients with lung cancer. Explore the data supporting endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) as a diagnostic and prognostic tool.

THORACIC ONCOLOGY & CHEST PROCEDURES NETWORK

Adjuvant and neoadjuvant therapies in early stage lung cancer
Review the latest data on the evolving landscape of targeted therapies for patients with lung cancer.

Role of EBUS for staging and prognostication in patients with lung cancer
What is the prognostic impact of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA)? This article explores current diagnostic tools and the role of invasive mediastinal staging in patients with T1 disease.

PRESS RELEASE

FIRS partners address tobacco industry for World No Tobacco Day
Read more about the specific concerns CHEST and other members of the Forum of International Respiratory Societies (FIRS) directed toward the tobacco industry.

GUIDELINES

Screening for Lung Cancer: CHEST Guideline and Expert Panel Report
Read the latest recommendations on lung cancer screening, including updates on the benefits, harms, and implementation of low-dose chest CT screening.

Advertisement

Join the Community

If you’re not already a CHEST member, become one today for access to additional resources, discounts on educational activities, and networking opportunities.

JOIN NOW »